New Delhi: India’s top vaccine advisory panel failed to reach a consensus on both the booster dose and the vaccination of children amid the rise in Omicron cases on Monday.
The National Technical Advisory Group on Immunization (NTAGI) discussed at length whether to allow an additional dose for immunocompromised people or those more at risk from the deadly virus.
However, no final recommendation was made, say reports. The group is also likely to formulate a policy on inoculating children — the only group left out of vaccinations so far.
“The meeting put light on COVID-19 vaccination, additional doses and vaccination for children but due to no consensus over the issues final recommendation couldn’t be made,” sources were quoted as saying by news agency ANI.
According to the panel members, a decision on boosters was not on the meeting’s agenda. The panel drew a distinction between a booster dose and an additional jab. If two doses fail to build immunity, an additional dose is given.
The government has, for now, held off on boosters. Health Minister Mansukh Mandaviya told parliament recently that NTAGI and the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) were deliberating and considering scientific evidence related to this aspect.
ALSO READ: Over 100 Foreign Returnees Go Untraceable Near Mumbai Amid Omicron Scare
Bhubaneswar: The arrest of ten Bangladeshi nationals in Bhubaneswar by the Special Task Force (STF)… Read More
Hyderabad/Bhubaneswar: Priyanka Chopra has returned to India and is expected to travel to Odisha, where… Read More
Chicago: Adding to Air India’s rather long list of woes, since the airline’s take over… Read More
Bhubaneswar: In an effort to enhance efficiency and transparency, the Odisha government has modified the… Read More
Mumbai: Much has been said and done over the last several months regarding Halal Certification… Read More
Bhubaneswar: As Odisha Assembly witnessed pandemonium over Sambalpur MLA Jayanarayan Mishra's controversial statement, Congress general… Read More
This website uses cookies.